newsfilter
← Latest News
GlobeNewswire·

Icosavax Announces Results from IVX-411 Drug Product Investigation and Outlines Additional Corporate Milestones

- Antigen component of IVX-411 found to be unstable; issue specific to molecule, with no evidence of read-through to other Icosavax programs - - Now focused on a bivalent strategy for COVID-19 candidate development displaying computationally engineere